RGEBX | TRGOX | RGEBX / TRGOX | |
Total Expense Ratio | 1.09 | 0.70 | 156% |
Annual Report Gross Expense Ratio | 1.09 | 0.75 | 145% |
Fund Existence | 11 years | 5 years | - |
Gain YTD | -4.941 | -6.549 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 280B | 20.6B | 1,359% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -0.53 | 3.84 | -14% |
Returns for 3 years | 3.55 | 17.41 | 20% |
Returns for 5 years | 66.95 | N/A | - |
Returns for 10 years | 53.92 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LMBS | 49.26 | 0.09 | +0.18% |
First Trust Low Duration Oppos ETF | |||
FTXH | 26.59 | -0.42 | -1.55% |
First Trust Nasdaq Pharmaceuticals ETF | |||
HNDL | 20.77 | -0.33 | -1.56% |
Strategy Shares Nasdaq 7 Handl™ ETF | |||
FITE | 60.51 | -3.69 | -5.75% |
SPDR® S&P Kensho Future Security ETF | |||
TDV | 68.16 | -5.19 | -7.08% |
ProShares S&PTech Div Arstcrts ETF |